Daiwa Securities Group Inc. Aerie Pharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$9.12 - $14.49 $1,450 - $2,303	-159 Reduced 60.92%	102 $1,000
Q4 2019 Jan 31, 2020	SELL	$17.72 - $25.1 $496 - $702	-28 Reduced 9.69%	261 $6,000
Q1 2019 Apr 26, 2019	BUY	$36.32 - $49.25 $3,123 - $4,235	86 Added 42.36%	289 $14,000
Q1 2018 May 02, 2018	BUY	$51.15 - $61.0 $10,383 - $12,383	203 New	203 $11,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.